logo
Select company
Select metric
$ 5.77MNet Cash Flow - Financing
VS
Market
37
Sector
51
Industry
60
History
93
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information

Ticker

XFOR

Company Name

X4 PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

X4 PHARMACEUTICALS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XFOR - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 5.77M
3/31/2025$ 20.29M
12/31/2024$ 20.29M
9/30/2024$ 20.26M
6/30/2024$ 41.46M
3/31/2024$ 90.64M
12/31/2023$ 88.52M
9/30/2023$ 149.06M
6/30/2023$ 179.84M
3/31/2023$ 110.15M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 65.05M.
  • Over the past 5 years, X4 PHARMACEUTICALS INC's average CF - Financing has been $ 65.32M.
  • The median CF - Financing for X4 PHARMACEUTICALS INC during this period was $ 61.96M
  • X4 PHARMACEUTICALS INC reached its highest CF - Financing over the past 5 years at $ 179.84M.
  • The lowest CF - Financing recorded by X4 PHARMACEUTICALS INC in the same timeframe $ 5.77M

X4 PHARMACEUTICALS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
AMS : AMERICAN SHARED HOSPITAL SERVICES $ 4.95MBNGO : BIONANO GENOMICS INC $ 22.27MCRIS : CURIS INC $ 12.71MMRKR : MARKER THERAPEUTICS INC $ 14.9MLPCN : LIPOCINE INC $ 75.62KDRIO : DARIOHEALTH CORP $ 25.26MGBIO : GENERATION BIO CO $ 214KBCAB : BIOATLA INC $ 8.87MCARM : CARISMA THERAPEUTICS INC $ -1.71MPULM : PULMATRIX INC $ 0

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

XFOR - Net Cash Flow - Financing, Last 5 years

$ 5.77M

Minimum

Jun 30, 2025

$ 179.84M

Maximum

Jun 30, 2023

$ 65.32M

Average

$ 61.96M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.91M with a standard deviation of $ 118.69M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -365.75M
max$ 365M
average$ -6.91M
median$ 314K
std$ 118.69M